The anti-mRNA sentiment — coupled with the sweeping shake-up of science funding across the United States — has sparked fears ...

As the field of personalized medicine evolves, digital technologies are playing a central role in revolutionizing cancer ...

Have you ever wondered about what became of COVID vaccine companies after the pandemic settled down? Find out in this article ...

The technology is genuinely useful for scientific discovery, but its applications are less dramatic than you might think.

Clinical trials for the NIH's new universal flu vaccine are anticipated by 2026, with FDA approval by 2029. Other viruses ...

The US Department of Health and Human Services announced the government will invest $176 million in Moderna to expedite the creation of a pandemic influenza vaccine.

Kennedy won Senate confirmation to his job, in part, by promising not to change the nation’s vaccine schedule. Since taking ...

A scientific revolution is underway as researchers push to bring atomic-level precision, once reserved for small molecule ...

Novavax faces uncertainty as FDA requests a new clinical trial for its COVID-19 vaccine, the last protein-based option in the ...

Company aims to develop a bird flu vaccine with rapid mass production and variant responsiveness. SK bioscience and KDCA join ...